tocilizumab

Dr. Reddy’s Laboratories shares gained on Monday in the backdrop of the drugmaker announcing successful completion of a phase-1 study of its proposed biosimilar of tocilizumab for use in the…

CAMBRIDGE, Mass., Sept. 30, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application…

About half of patients with steroid-dependent polymyalgia rheumatica (PMR) were able to get…

CAMBRIDGE, Mass. and GUANGZHOU, China, June 03, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Bio-Thera Solutions, Ltd. (688177.SH) today presented positive Phase 3 data for…

The new guidelines prescribe Remdesivir (EUA) to be considered only in patients within 10 days of onset of symptoms to those having moderate to severe disease (requiring supplemental…

While the FDA's June authorization of tocilizumab (Actemra) for severe COVID-19 was a welcome…

This authorisation will enable medical practitioners to use the drug for the treatment of COVID-19 in hospitalised adults who are receiving systemic corticosteroids and require supplemental…

Note that some links may require registration or subscription. What's prompting talk of booster…

The analysis included information on 10,930 patients, of whom 6,449 were randomly assigned to receive interleukin-6 inhibitors and 4,481 to receive usual care or…

Tocilizumab (Actemra), an interleukin-6 (IL-6) inhibitor, was authorized to treat certain…